ClearPoint Neuro (CLPT) Total Debt Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -0.07% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.11% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 1.72% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -0.34% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -14.39% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 71.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.12% |
| Dec 31, 2025 | 70.55% |
| Sep 30, 2025 | 43.52% |
| Jun 30, 2025 | 43.00% |
| Dec 31, 2023 | -26.44% |
| Sep 30, 2023 | 122.99% |
| Jun 30, 2023 | 122.89% |
| Mar 31, 2023 | -17.28% |
| Dec 31, 2022 | 68.36% |
| Sep 30, 2022 | 74.25% |
| Jun 30, 2022 | 74.11% |
| Mar 31, 2022 | 71.74% |
| Dec 31, 2021 | 71.81% |
| Sep 30, 2021 | 108.80% |
| Jun 30, 2021 | 137.99% |
| Mar 31, 2021 | 174.15% |
| Dec 31, 2020 | 133.24% |
| Dec 31, 2019 | -0.92% |
| Sep 30, 2019 | -8.64% |
| Jun 30, 2019 | -15.39% |
| Mar 31, 2019 | -25.94% |
| Dec 31, 2018 | 19.98% |
| Sep 30, 2018 | 5.78% |
| Jun 30, 2018 | -33.93% |
| Mar 31, 2018 | -44.73% |
| Dec 31, 2017 | -31.82% |
| Dec 31, 2016 | -34.55% |
| Sep 30, 2016 | -17.26% |
| Jun 30, 2016 | -22.54% |
| Mar 31, 2016 | -14.13% |
| Dec 31, 2015 | -35.20% |
| Sep 30, 2015 | -24.79% |
| Jun 30, 2015 | 174.07% |
| Mar 31, 2015 | 231.60% |
| Dec 31, 2014 | 217.45% |